Seminars in Oncology
Volume 35, Issue 1 , Pages 78-86 , February 2008

The Role of Locoregional Therapy in Inflammatory Breast Cancer

  • Wendy A. Woodward

      Affiliations

    • Corresponding Author InformationAddress correspondence to Wendy Woodward, MD, Department of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030.
    • ,
  • Thomas A. Buchholz

References 

  1. Early Breast Cancer Trialists’ Collaborative Group. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366:2087–2106
  2. Bozzetti F, Saccozzi R, De Lena M, Salvadori B. Inflammatory cancer of the breast: analysis of 114 cases. J Surg Oncol. 1981;18:355–361
  3. Barker JL, Nelson AJ, Montague ED. Inflammatory carcinoma of the breast. Radiology. 1976;121:173–176
  4. Zucali R, Uslenghi C, Kenda R, Bonadonna G. Natural history and survival of inoperable breast cancer treated with radiotherapy and radiotherapy followed by radical mastectomy. Cancer. 1976;37:1422–1431
  5. Fields JN, Perez CA, Kuske RR, Fineberg BB, Bartlett N. Inflammatory carcinoma of the breast: treatment results on 107 patients. Int J Radiat Oncol Biol Phys. 1989;17:249–255
  6. Barker JL, Montague ED, Peters LJ. Clinical experience with irradiation of inflammatory carcinoma of the breast with and without elective chemotherapy. Cancer. 1980;45:625–629
  7. Horst KC, Smitt MC, Goffinet DR, Carlson RW. Predictors of local recurrence after breast-conservation therapy. Clin Breast Cancer. 5:425-38.
  8. Laskar SG, Agarwal JP, Srinivas C, Dinshaw KA. Radiotherapeutic management of locally advanced head and neck cancer. Expert Rev Anticancer Ther. 2006;6:405–417
  9. Dreyer G. Operative management of cervical cancer. Best Pract Res Clin Obstet Gynaecol. 2005;19:563–576
  10. Chang SS, Cookson MS. Impact of positive surgical margins after radical prostatectomy. Urology. 2006;68:249–252
  11. Curcio LD, Rupp E, Williams WL, Chu DZ, Clarke K, Odom-Maryon T, et al. Beyond palliative mastectomy in inflammatory breast cancer—a reassessment of margin status. Ann Surg Oncol. 1999;6:249–254
  12. Low JA, Berman AW, Steinberg SM, Danforth DN, Lippman ME, Swain SM. Long-term follow-up for locally advanced and inflammatory breast cancer patients treated with multimodality therapy. J Clin Oncol. 2004;22:4067–4074
  13. Brun B, Otmezguine Y, Feuilhade F, Julien M, Lebourgeois JP, Calitchi E, et al. Treatment of inflammatory breast cancer with combination chemotherapy and mastectomy versus breast conservation. Cancer. 1988;61:1096–1103
  14. Chevallier B, Asselain B, Kunlin A, Veyret C, Bastit P, Graic Y. Inflammatory breast cancer (Determination of prognostic factors by univariate and multivariate analysis). Cancer. 1987;60:897–902
  15. Arthur DW, Schmidt-Ullrich RK, Friedman RB, et al. Accelerated superfractionated radiotherapy for inflammatory breast carcinoma: complete response predicts outcome and allows for breast conservation. Int J Radiat Oncol Biol Phys. 1999;44:289–296
  16. Motwani SB, Strom EA, Schechter NR, Butler CE, Lee GK, Langstein HN, et al. The impact of immediate breast reconstruction on the technical delivery of postmastectomy radiotherapy. Int J Radiat Oncol Biol Phys. 2006;66:76–82
  17. Babiera GV, Rao R, Feng L, Meric-Bernstam F, Kuerer HM, Singletary SE, et al. Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and an intact primary tumor. Ann Surg Oncol. 2006;13:776–782
  18. Rapiti E, Verkooijen HM, Vlastos G, Fioretta G, Neyroud-Caspar I, Sappino AP, et al. Complete excision of primary breast tumor improves survival of patients with metastatic breast cancer at diagnosis. J Clin Oncol. 2006;24:2743–2749
  19. Bese NS, Hendry J, Jeremic B. Effects of prolongation of overall treatment time due to unplanned interruptions during radiotherapy of different tumor sites and practical methods for compensation. Int J Radiat Oncol Biol Phys. 2007;68:654–661
  20. Bese NS, Sut PA, Ober A. The effect of treatment interruptions in the postoperative irradiation of breast cancer. Oncology. 2005;69:214–223
  21. Hershman DL, Wang X, McBride R, Jacobson JS, Grann VR, Neugut AI. Delay in initiating adjuvant radiotherapy following breast conservation surgery and its impact on survival. Int J Radiat Oncol Biol Phys. 2006;65:1353–1360
  22. Thoms WW, McNeese MD, Fletcher GH, Buzdar AU, Singletary SE, Oswald MJ. Multimodal treatment for inflammatory breast cancer. Int J Radiat Oncol Biol Phys. 1989;17:739–745
  23. Liao Z, Strom EA, Buzdar AU, Singletary SE, Hunt K, Allen PK, et al. Locoregional irradiation for inflammatory breast cancer: effectiveness of dose escalation in decreasing recurrence. Int J Radiat Oncol Biol Phys. 2000;47:1191–1200
  24. Eifel PJ. Chemoradiotherapy in the treatment of cervical cancer. Semin Radiat Oncol. 2006;16:177–185
  25. Cox JD. Chemoradiation for malignant epithelial tumors. Cancer Radiother. 1998;2:7–11

PII: S0093-7754(07)00234-5

doi: 10.1053/j.seminoncol.2007.11.009

Seminars in Oncology
Volume 35, Issue 1 , Pages 78-86 , February 2008

Article Tools

* Image Usage & Resolution